Antifibrotic drugs like pirfenidone (Esbriet; Genentech) and nintedanib (Ofev; Boehringer Ingelheim) have been shown to be effective in patients with idiopathic pulmonary fibrosis (IPF) and in some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback